Thiotepa/topotecan/carboplatin (TTC) with autologous stem cell rescue (ASCR) in recurrent/refractory/poor prognosis pediatric malignancies of the CNS

被引：0
|
作者：
Gilheeney, Stephen [1 ]
Dunkel, Ira [1 ]
Khakoo, Yasmin [1 ]
Souweidane, Mark [2 ]
Wolden, Suzanne
Boulad, Farid [1 ]
Kushner, Brian [1 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, Dept Pediat, New York, NY 10021 USA
[2] Mem Sloan Kettering Canc Ctr, Dept Neurosurg, New York, NY 10021 USA
来源：
NEURO-ONCOLOGY | 2008年 / 10卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：423 / 423
页数：1
相关论文
共 50 条
  • [1] Thiotepa/Topotecan/Carboplatin With Autologous Stem Cell Rescue in Recurrent/Refractory/Poor Prognosis Pediatric Malignancies of the Central Nervous System
    Gilheeney, Stephen W.
    Khakoo, Yasmin
    Souweidane, Mark
    Wolden, Suzanne
    Boulad, Farid
    Dunkel, Ira J.
    [J]. PEDIATRIC BLOOD & CANCER, 2010, 54 (04) : 591 - 595
  • [2] High-dose carboplatin, thiotepa, and etoposide with autologous stem cell rescue (ASCR) for recurrent medulloblastoma
    Dunkel, I
    Gardner, S
    Garvin, J
    Goldman, S
    Shi, WJ
    Finlay, J
    [J]. NEURO-ONCOLOGY, 2004, 6 (04) : 453 - 453
  • [3] Tandem thiotepa with autologous hematopoietic cell rescue in patients with recurrent, refractory, or poor prognosis solid tumor malignancies
    Osorio, Diana S.
    Dunkel, Ira J.
    Cervone, Kelly Ann
    Goyal, Rakesh K.
    Lo, K. M. Steve
    Finlay, Jonathan L.
    Gardner, Sharon L.
    [J]. PEDIATRIC BLOOD & CANCER, 2018, 65 (01)
  • [4] High-dose carboplatin, thiotepa, and etoposide with autologous stem cell rescue (ASCR) for patients with previously irradiated recurrent medulloblastoma
    Dunkel, Ira
    Gardner, Sharon
    Garvin, James
    Goldman, Stewart
    Shi, Weiji
    Finlay, Jonathan
    [J]. NEURO-ONCOLOGY, 2008, 10 (03) : 480 - 480
  • [5] Phase 1 dose escalation of temozolomide with thictepa and carboplatin with autologous stem cell rescue (ASCR) in pataients with recurrent/refractory central nervous system (CNS) tumors
    Gardner, S
    Baker, D
    Belasco, J
    Phillips, P
    Bunin, N
    Grupp, S
    Iannone, R
    Knopp, E
    Miller, D
    Cervone, K
    Ngo, H
    Finlay, J
    [J]. NEURO-ONCOLOGY, 2004, 6 (04) : 455 - 455
  • [6] HIGH-DOSE THIOTEPA AND MITOXANTRONE (MITT) FOLLOWED BY AUTOLOGOUS STEM-CELL RESCUE (ASCR) FOR REFRACTORY CANCER
    FIELDS, K
    ELFENBEIN, G
    HIEMENZ, J
    ZORSKY, P
    PERKINS, J
    GONZALEZ, J
    GREENE, S
    OELSLAGER, P
    KRONISH, L
    HOLCOMB, D
    MACHAK, M
    SULLIVAN, P
    PACH, L
    [J]. EXPERIMENTAL HEMATOLOGY, 1992, 20 (06) : 714 - 714
  • [7] High-dose chemotherapy containing topotecan, thiotepa and carboplatin with autologous stem cell rescue for high-risk medulloblastorna
    Muramatsu, H
    Matsumoto, K
    Kato, K
    Inao, S
    [J]. BONE MARROW TRANSPLANTATION, 2005, 35 : S390 - S390
  • [8] High-dose carboplatin, thiotepa, and etoposide with autologous stem-cell rescue for patients with recurrent medulloblastoma
    Dunkel, IJ
    Boyett, JM
    Yates, A
    Rosenblum, M
    Garvin, JH
    Bostrom, BC
    Goldman, S
    Sender, LS
    Gardner, SL
    Li, H
    Allen, JC
    Finlay, JL
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (01) : 222 - 228
  • [9] Myeloablative Carboplatin and Thiotepa With Autologous Stem Cell Rescue for Nonmedulloblastoma High-risk CNS Tumors in Young Children
    Fries, Carol
    Girvin, Angela R.
    Korones, David N.
    Weintraub, Lauren
    Fitzpatrick, Lorna
    Andolina, Jeffrey R.
    [J]. JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2021, 43 (08) : E1223 - E1227
  • [10] High-dose chemotherapy (HDQ with autologous stem cell rescue (ASCR) in patients with recurrent CNS germ cell tumors (GCT)
    Gardner, S
    Modak, S
    Allen, J
    Finlay, J
    [J]. NEURO-ONCOLOGY, 2005, 7 (04) : 522 - 522
12345